Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Cancer Immunotherapymarket was valued at USD 61.88billion in 2016 and is projected to reach USD 200.44billionby 2025, growing at a CAGR of 13.95% from 2017 to 2025.
Immunotherapy is treatment that uses certain parts of a person's immune system to fight diseases. Cancer is prevalent all over the globe causing the demand of efficient treatment methods to increase. The market is expected to grow at a high rate.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Rise in Incidence of Cancer
1.2 Increase in Adoption of Immunotherapy
1.3 Development of Bioinformatics Tools
2. Market Restraints
2.1 Cost Constraints
Market Segmentation:
1. By End User:
1.1 Hospitals
1.2 Clinics & Others
2. By Application:
2.1 Lung Cancer
2.2 Breast Cancer
2.3 Multiple Myeloma
2.4 Colorectal Cancer
2.5 Head & Neck Cancer
2.6 Prostate Cancer
2.7 Melanoma
2.8 Other Cancer Types
3. By Product Type:
3.1 Monoclonal Antibodies
3.1.1 Naked Monoclonal Antibodies
3.1.2 Conjugated Monoclonal Antibodies
3.1.3 Bispecific Monoclonal Antibodies
3.2 Vaccines
3.2.1 Prophylactic Vaccines
3.2.2 Therapeutic Vaccines
3.3 Checkpoint Inhibitors
3.3.1 Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4)
3.3.2 Programmed Death 1 (PD-1) & Programmed Death Ligand 1 (PD-L1)
3.4 Cell Therapies
3.4.1 Chimeric Antigen Receptor (CAR) T Cell Therapy
3.4.2 Dendritic Cells
3.5 Immuno modulators
3.5.1 Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf& G-Csf)
3.5.2 Interferons (IFN)
3.5.3 Interleukins (IL)
3.5.4 Oncolytic Virus
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Amgen Inc.
2. Astrazeneca
3. Bayer AG
4. Bristol-Myers Squibb
5. ELI Lilly and Company
6. Janssen Global Services, LLC (Johnson and Johnson)
7. Merck
8. Novartis
9. Pfizer
10. F. Hoffmann-La Roche Ltd
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cancer Immunotherapymarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Request Sample 
Request Discount 
Inquire Before Buy
